Lilly Bourguignon, PhD

Title(s)Professor, Medicine
SchoolSchool of Medicine
AddressVAMC
San Francisco CA 94121
Phone415-221-4810 ext. 3321
vCardDownload vCard

    Collapse Overview 

    Collapse Research 
    Collapse Research Activities and Funding
    Selective Hyaluronan Treatment to Overcome Age-related Epidermal Dysfunction
    NIH I01RX000601Apr 1, 2013 - Mar 31, 2017
    Role: Principal Investigator
    CD44 & Stem Cell Marker (Nanog) in Head and Neck Cancer
    NIH I01BX000628Oct 1, 2010 - Sep 30, 2014
    Role: Principal Investigator
    CD44-p185HER2 Interaction in Ovarian Cancer Progression
    NIH R01CA078633Apr 1, 1999 - Jan 31, 2010
    Role: Principal Investigator
    CD44/Variant Cytoskeleton in Breast Cancer Progression
    NIH R01CA066163Apr 1, 1995 - May 31, 2014
    Role: Principal Investigator
    BIOCHEMICAL &CYTOCHEMICAL STUDIES ON LYMPHOID MEMBRANE
    NIH R01GM036353Jan 1, 1982 - Jun 30, 1996
    Role: Principal Investigator
    BIOCHEMICAL AND IMMUNOCYTOCHEMICAL LYMPHOCYTE STUDIES
    NIH R01AI019188Jan 1, 1982 - Dec 31, 1986
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Matrix Hyaluronan-CD44 Interaction Activates MicroRNA and LncRNA Signaling Associated With Chemoresistance, Invasion, and Tumor Progression. Front Oncol. 2019; 9:492. Bourguignon LYW. PMID: 31293964; PMCID: PMC6598393.
      View in: PubMed   Mentions: 21  
    2. Hyaluronan-CD44 interaction promotes HPV 16 E6 oncogene-mediated oropharyngeal cell carcinoma survival and chemoresistance. Matrix Biol. 2019 05; 78-79:180-200. Bourguignon LYW, Earle C, Shiina M. PMID: 30077625.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansAnimalsCells
    3. Activation of Matrix Hyaluronan-Mediated CD44 Signaling, Epigenetic Regulation and Chemoresistance in Head and Neck Cancer Stem Cells. Int J Mol Sci. 2017 Aug 24; 18(9). Bourguignon LYW, Earle C, Shiina M. PMID: 28837080; PMCID: PMC5618498.
      View in: PubMed   Mentions: 31     Fields:    Translation:HumansAnimalsCells
    4. Matrix Hyaluronan Promotes Specific MicroRNA Upregulation Leading to Drug Resistance and Tumor Progression. Int J Mol Sci. 2016 Apr 07; 17(4):517. Bourguignon LY. PMID: 27070574; PMCID: PMC4848973.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansAnimalsCells
    5. Up-regulation of Histone Methyltransferase, DOT1L, by Matrix Hyaluronan Promotes MicroRNA-10 Expression Leading to Tumor Cell Invasion and Chemoresistance in Cancer Stem Cells from Head and Neck Squamous Cell Carcinoma. J Biol Chem. 2016 May 13; 291(20):10571-85. Bourguignon LY, Wong G, Shiina M. PMID: 27002147; PMCID: PMC4865907.
      View in: PubMed   Mentions: 25     Fields:    Translation:HumansCells
    6. Selective Activation of Cancer Stem Cells by Size-Specific Hyaluronan in Head and Neck Cancer. Int J Cell Biol. 2015; 2015:989070. Shiina M, Bourguignon LY. PMID: 26448762; PMCID: PMC4581563.
      View in: PubMed   Mentions: 12  
    7. Identification of novel drugs to target dormant micrometastases. BMC Cancer. 2015 May 14; 15:404. Hurst RE, Hauser PJ, You Y, Bailey-Downs LC, Bastian A, Matthews SM, Thorpe J, Earle C, Bourguignon LY, Ihnat MA. PMID: 25971923; PMCID: PMC4434572.
      View in: PubMed   Mentions: 7     Fields:    Translation:AnimalsCells
    8. Selective Hyaluronan-CD44 Signaling Promotes miRNA-21 Expression and Interacts with Vitamin D Function during Cutaneous Squamous Cell Carcinomas Progression Following UV Irradiation. Front Immunol. 2015; 6:224. Bourguignon LY, Bikle D. PMID: 26029210; PMCID: PMC4429634.
      View in: PubMed   Mentions: 10     Fields:    
    9. New developmental data for Cynomya mortuorum (L., 1761) in Belgium (Diptera: Calliphoridae). Forensic Sci Int. 2015 Jul; 252:29-32. Braet Y, Bourguignon L, Vanpoucke S, Drome V, Hubrecht F. PMID: 25933426.
      View in: PubMed   Mentions: 2     Fields:    Translation:Animals
    10. Matrix hyaluronan-activated CD44 signaling promotes keratinocyte activities and improves abnormal epidermal functions. Am J Pathol. 2014 Jul; 184(7):1912-9. Bourguignon LY. PMID: 24819962; PMCID: PMC4076472.
      View in: PubMed   Mentions: 38     Fields:    Translation:HumansAnimalsCells
    11. Hyaluronan-CD44 interaction promotes c-Jun signaling and miRNA21 expression leading to Bcl-2 expression and chemoresistance in breast cancer cells. Mol Cancer. 2014 Mar 08; 13:52. Chen L, Bourguignon LY. PMID: 24606718; PMCID: PMC3975292.
      View in: PubMed   Mentions: 51     Fields:    Translation:HumansCells
    12. The inhibition of miR-21 promotes apoptosis and chemosensitivity in ovarian cancer. Gynecol Oncol. 2014 Mar; 132(3):739-44. Chan JK, Blansit K, Kiet T, Sherman A, Wong G, Earle C, Bourguignon LY. PMID: 24472409.
      View in: PubMed   Mentions: 60     Fields:    Translation:HumansCells
    13. Hyaluronan-CD44 interaction promotes oncogenic signaling, microRNA functions, chemoresistance, and radiation resistance in cancer stem cells leading to tumor progression. Adv Cancer Res. 2014; 123:255-75. Bourguignon LY, Shiina M, Li JJ. PMID: 25081533; PMCID: PMC6759082.
      View in: PubMed   Mentions: 62     Fields:    Translation:HumansAnimalsCells
    14. Selective matrix (hyaluronan) interaction with CD44 and RhoGTPase signaling promotes keratinocyte functions and overcomes age-related epidermal dysfunction. J Dermatol Sci. 2013 Oct; 72(1):32-44. Bourguignon LY, Wong G, Xia W, Man MQ, Holleran WM, Elias PM. PMID: 23790635; PMCID: PMC3775883.
      View in: PubMed   Mentions: 24     Fields:    Translation:HumansAnimalsCells
    15. Hyaluronan-CD44v3 interaction with Oct4-Sox2-Nanog promotes miR-302 expression leading to self-renewal, clonal formation, and cisplatin resistance in cancer stem cells from head and neck squamous cell carcinoma. J Biol Chem. 2012 Sep 21; 287(39):32800-24. Bourguignon LY, Wong G, Earle C, Chen L. PMID: 22847005; PMCID: PMC3463333.
      View in: PubMed   Mentions: 117     Fields:    Translation:HumansCells
    16. Role of hyaluronan synthase 2 to promote CD44-dependent oral cavity squamous cell carcinoma progression. Head Neck. 2013 Apr; 35(4):511-20. Wang SJ, Earle C, Wong G, Bourguignon LY. PMID: 22473523.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansCells
    17. Hyaluronan-CD44 interaction promotes microRNA signaling and RhoGTPase activation leading to tumor progression. Small GTPases. 2012 Jan-Mar; 3(1):53-9. Bourguignon LY. PMID: 22714418; PMCID: PMC3398919.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansCells
    18. Interaction of low molecular weight hyaluronan with CD44 and toll-like receptors promotes the actin filament-associated protein 110-actin binding and MyD88-NFκB signaling leading to proinflammatory cytokine/chemokine production and breast tumor invasion. Cytoskeleton (Hoboken). 2011 Dec; 68(12):671-93. Bourguignon LY, Wong G, Earle CA, Xia W. PMID: 22031535; PMCID: PMC3240717.
      View in: PubMed   Mentions: 44     Fields:    Translation:HumansAnimalsCells
    19. Stem cell marker (Nanog) and Stat-3 signaling promote MicroRNA-21 expression and chemoresistance in hyaluronan/CD44-activated head and neck squamous cell carcinoma cells. Oncogene. 2012 Jan 12; 31(2):149-60. Bourguignon LY, Earle C, Wong G, Spevak CC, Krueger K. PMID: 21685938; PMCID: PMC3179812.
      View in: PubMed   Mentions: 119     Fields:    Translation:HumansCells
    20. Role of hyaluronan-mediated CD44 signaling in head and neck squamous cell carcinoma progression and chemoresistance. Am J Pathol. 2011 Mar; 178(3):956-63. Wang SJ, Bourguignon LY. PMID: 21356346; PMCID: PMC3069910.
      View in: PubMed   Mentions: 71     Fields:    Translation:HumansCells
    21. Hyaluronan-CD44 interaction promotes c-Src-mediated twist signaling, microRNA-10b expression, and RhoA/RhoC up-regulation, leading to Rho-kinase-associated cytoskeleton activation and breast tumor cell invasion. J Biol Chem. 2010 Nov 19; 285(47):36721-35. Bourguignon LY, Wong G, Earle C, Krueger K, Spevak CC. PMID: 20843787; PMCID: PMC2978601.
      View in: PubMed   Mentions: 101     Fields:    Translation:HumansCells
    22. Reduction of hyaluronan-CD44-mediated growth, migration, and cisplatin resistance in head and neck cancer due to inhibition of Rho kinase and PI-3 kinase signaling. Arch Otolaryngol Head Neck Surg. 2010 May; 136(5):493-501. Torre C, Wang SJ, Xia W, Bourguignon LY. PMID: 20479382; PMCID: PMC2874205.
      View in: PubMed   Mentions: 29     Fields:    Translation:HumansCells
    23. CD44 variant isoforms in head and neck squamous cell carcinoma progression. Laryngoscope. 2009 Aug; 119(8):1518-30. Wang SJ, Wong G, de Heer AM, Xia W, Bourguignon LY. PMID: 19507218; PMCID: PMC2718060.
      View in: PubMed   Mentions: 71     Fields:    Translation:HumansCells
    24. Hyaluronan-CD44 interaction with protein kinase C(epsilon) promotes oncogenic signaling by the stem cell marker Nanog and the Production of microRNA-21, leading to down-regulation of the tumor suppressor protein PDCD4, anti-apoptosis, and chemotherapy resistance in breast tumor cells. J Biol Chem. 2009 Sep 25; 284(39):26533-46. Bourguignon LY, Spevak CC, Wong G, Xia W, Gilad E. PMID: 19633292; PMCID: PMC2785342.
      View in: PubMed   Mentions: 150     Fields:    Translation:HumansCells
    25. Cadaveric volatile organic compounds released by decaying pig carcasses (Sus domesticus L.) in different biotopes. Forensic Sci Int. 2009 Aug 10; 189(1-3):46-53. Dekeirsschieter J, Verheggen FJ, Gohy M, Hubrecht F, Bourguignon L, Lognay G, Haubruge E. PMID: 19423246.
      View in: PubMed   Mentions: 31     Fields:    Translation:AnimalsCellsPHPublic Health
    26. The role of CD44 in cutaneous inflammation. Exp Dermatol. 2009 Nov; 18(11):962-8. Man M, Elias PM, Man W, Wu Y, Bourguignon LY, Feingold KR, Man MQ. PMID: 19469887; PMCID: PMC2784008.
      View in: PubMed   Mentions: 9     Fields:    Translation:AnimalsCells
    27. Matrix metalloproteinase-9 facilitates glial scar formation in the injured spinal cord. J Neurosci. 2008 Dec 10; 28(50):13467-77. Hsu JY, Bourguignon LY, Adams CM, Peyrollier K, Zhang H, Fandel T, Cun CL, Werb Z, Noble-Haeusslein LJ. PMID: 19074020; PMCID: PMC2712293.
      View in: PubMed   Mentions: 71     Fields:    Translation:AnimalsCells
    28. Hyaluronan-mediated CD44 interaction with p300 and SIRT1 regulates beta-catenin signaling and NFkappaB-specific transcription activity leading to MDR1 and Bcl-xL gene expression and chemoresistance in breast tumor cells. J Biol Chem. 2009 Jan 30; 284(5):2657-2671. Bourguignon LYW, Xia W, Wong G. PMID: 19047049; PMCID: PMC2631959.
      View in: PubMed   Mentions: 77     Fields:    Translation:HumansCells
    29. Hyaluronan-CD44 interaction activates stem cell marker Nanog, Stat-3-mediated MDR1 gene expression, and ankyrin-regulated multidrug efflux in breast and ovarian tumor cells. J Biol Chem. 2008 Jun 20; 283(25):17635-51. Bourguignon LY, Peyrollier K, Xia W, Gilad E. PMID: 18441325; PMCID: PMC2427357.
      View in: PubMed   Mentions: 206     Fields:    Translation:HumansCells
    30. Hyaluronan-mediated CD44 activation of RhoGTPase signaling and cytoskeleton function promotes tumor progression. Semin Cancer Biol. 2008 Aug; 18(4):251-9. Bourguignon LY. PMID: 18450475; PMCID: PMC2505114.
      View in: PubMed   Mentions: 126     Fields:    Translation:HumansAnimalsCells
    31. Association of CD44 V3-containing isoforms with tumor cell growth, migration, matrix metalloproteinase expression, and lymph node metastasis in head and neck cancer. Head Neck. 2007 Jun; 29(6):550-8. Wang SJ, Wreesmann VB, Bourguignon LY. PMID: 17252589.
      View in: PubMed   Mentions: 38     Fields:    Translation:HumansCells
    32. Heregulin-mediated ErbB2-ERK signaling activates hyaluronan synthases leading to CD44-dependent ovarian tumor cell growth and migration. J Biol Chem. 2007 Jul 06; 282(27):19426-41. Bourguignon LY, Gilad E, Peyrollier K. PMID: 17493932.
      View in: PubMed   Mentions: 75     Fields:    Translation:HumansAnimalsCells
    33. Hyaluronan-CD44 interaction stimulates Rac1 signaling and PKN gamma kinase activation leading to cytoskeleton function and cell migration in astrocytes. J Neurochem. 2007 May; 101(4):1002-17. Bourguignon LY, Gilad E, Peyrollier K, Brightman A, Swanson RA. PMID: 17403031.
      View in: PubMed   Mentions: 41     Fields:    Translation:AnimalsCells
    34. The influence of hyaluronan-CD44 interaction on topoisomerase II activity and etoposide cytotoxicity in head and neck cancer. Arch Otolaryngol Head Neck Surg. 2007 Mar; 133(3):281-8. Wang SJ, Peyrollier K, Bourguignon LY. PMID: 17372087.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansCells
    35. Hyaluronan-CD44 interaction with neural Wiskott-Aldrich syndrome protein (N-WASP) promotes actin polymerization and ErbB2 activation leading to beta-catenin nuclear translocation, transcriptional up-regulation, and cell migration in ovarian tumor cells. J Biol Chem. 2007 Jan 12; 282(2):1265-80. Bourguignon LY, Peyrollier K, Gilad E, Brightman A. PMID: 17092940.
      View in: PubMed   Mentions: 42     Fields:    Translation:HumansAnimalsCells
    36. Hyaluronan and the interaction between CD44 and epidermal growth factor receptor in oncogenic signaling and chemotherapy resistance in head and neck cancer. Arch Otolaryngol Head Neck Surg. 2006 Jul; 132(7):771-8. Wang SJ, Bourguignon LY. PMID: 16847188.
      View in: PubMed   Mentions: 75     Fields:    Translation:HumansCells
    37. Hyaluronan-CD44 interaction stimulates keratinocyte differentiation, lamellar body formation/secretion, and permeability barrier homeostasis. J Invest Dermatol. 2006 Jun; 126(6):1356-65. Bourguignon LY, Ramez M, Gilad E, Singleton PA, Man MQ, Crumrine DA, Elias PM, Feingold KR. PMID: 16557236.
      View in: PubMed   Mentions: 45     Fields:    Translation:HumansAnimalsCells
    38. Hyaluronan-CD44 interaction with leukemia-associated RhoGEF and epidermal growth factor receptor promotes Rho/Ras co-activation, phospholipase C epsilon-Ca2+ signaling, and cytoskeleton modification in head and neck squamous cell carcinoma cells. J Biol Chem. 2006 May 19; 281(20):14026-40. Bourguignon LY, Gilad E, Brightman A, Diedrich F, Singleton P. PMID: 16565089.
      View in: PubMed   Mentions: 102     Fields:    Translation:HumansCells
    39. Hyaluronan-CD44 promotes phospholipase C-mediated Ca2+ signaling and cisplatin resistance in head and neck cancer. Arch Otolaryngol Head Neck Surg. 2006 Jan; 132(1):19-24. Wang SJ, Bourguignon LY. PMID: 16415424.
      View in: PubMed   Mentions: 23     Fields:    Translation:HumansCells
    40. Calcium-induced human keratinocyte differentiation requires src- and fyn-mediated phosphatidylinositol 3-kinase-dependent activation of phospholipase C-gamma1. Mol Biol Cell. 2005 Jul; 16(7):3236-46. Xie Z, Singleton PA, Bourguignon LY, Bikle DD. PMID: 15872086; PMCID: PMC1165407.
      View in: PubMed   Mentions: 40     Fields:    Translation:HumansCells
    41. Hyaluronan-CD44 interaction with IQGAP1 promotes Cdc42 and ERK signaling, leading to actin binding, Elk-1/estrogen receptor transcriptional activation, and ovarian cancer progression. J Biol Chem. 2005 Mar 25; 280(12):11961-72. Bourguignon LY, Gilad E, Rothman K, Peyrollier K. PMID: 15655247.
      View in: PubMed   Mentions: 72     Fields:    Translation:HumansAnimalsCells
    42. Hyaluronan increases RANKL expression in bone marrow stromal cells through CD44. J Bone Miner Res. 2005 Jan; 20(1):30-40. Cao JJ, Singleton PA, Majumdar S, Boudignon B, Burghardt A, Kurimoto P, Wronski TJ, Bourguignon LY, Halloran BP. PMID: 15619667.
      View in: PubMed   Mentions: 30     Fields:    Translation:AnimalsCells
    43. Hyaluronan-CD44 interaction with Rac1-dependent protein kinase N-gamma promotes phospholipase Cgamma1 activation, Ca(2+) signaling, and cortactin-cytoskeleton function leading to keratinocyte adhesion and differentiation. J Biol Chem. 2004 Jul 09; 279(28):29654-69. Bourguignon LY, Singleton PA, Diedrich F. PMID: 15123640.
      View in: PubMed   Mentions: 26     Fields:    Translation:HumansAnimalsCells
    44. CD44 interaction with Na+-H+ exchanger (NHE1) creates acidic microenvironments leading to hyaluronidase-2 and cathepsin B activation and breast tumor cell invasion. J Biol Chem. 2004 Jun 25; 279(26):26991-7007. Bourguignon LY, Singleton PA, Diedrich F, Stern R, Gilad E. PMID: 15090545.
      View in: PubMed   Mentions: 158     Fields:    Translation:HumansAnimalsCells
    45. CD44 interaction with ankyrin and IP3 receptor in lipid rafts promotes hyaluronan-mediated Ca2+ signaling leading to nitric oxide production and endothelial cell adhesion and proliferation. Exp Cell Res. 2004 Apr 15; 295(1):102-18. Singleton PA, Bourguignon LY. PMID: 15051494.
      View in: PubMed   Mentions: 46     Fields:    Translation:AnimalsCells
    46. Hyaluronan-mediated CD44 interaction with RhoGEF and Rho kinase promotes Grb2-associated binder-1 phosphorylation and phosphatidylinositol 3-kinase signaling leading to cytokine (macrophage-colony stimulating factor) production and breast tumor progression. J Biol Chem. 2003 Aug 08; 278(32):29420-34. Bourguignon LY, Singleton PA, Zhu H, Diedrich F. PMID: 12748184.
      View in: PubMed   Mentions: 98     Fields:    Translation:HumansAnimalsCells
    47. CD44v10 interaction with Rho-kinase (ROK) activates inositol 1,4,5-triphosphate (IP3) receptor-mediated Ca2+ signaling during hyaluronan (HA)-induced endothelial cell migration. Cell Motil Cytoskeleton. 2002 Dec; 53(4):293-316. Singleton PA, Bourguignon LY. PMID: 12378540.
      View in: PubMed   Mentions: 31     Fields:    Translation:AnimalsCells
    48. Hyaluronan promotes signaling interaction between CD44 and the transforming growth factor beta receptor I in metastatic breast tumor cells. J Biol Chem. 2002 Oct 18; 277(42):39703-12. Bourguignon LY, Singleton PA, Zhu H, Zhou B. PMID: 12145287.
      View in: PubMed   Mentions: 89     Fields:    Translation:HumansAnimalsCells
    49. Signaling properties of hyaluronan receptors. J Biol Chem. 2002 Feb 15; 277(7):4589-92. Turley EA, Noble PW, Bourguignon LY. PMID: 11717317.
      View in: PubMed   Mentions: 307     Fields:    Translation:HumansAnimalsCells
    50. Hyaluronan promotes CD44v3-Vav2 interaction with Grb2-p185(HER2) and induces Rac1 and Ras signaling during ovarian tumor cell migration and growth. J Biol Chem. 2001 Dec 28; 276(52):48679-92. Bourguignon LY, Zhu H, Zhou B, Diedrich F, Singleton PA, Hung MC. PMID: 11606575.
      View in: PubMed   Mentions: 72     Fields:    Translation:HumansAnimalsCells
    51. Amino acids in the cytoplasmic C terminus of the parathyroid Ca2+-sensing receptor mediate efficient cell-surface expression and phospholipase C activation. J Biol Chem. 2001 Nov 23; 276(47):44129-36. Chang W, Pratt S, Chen TH, Bourguignon L, Shoback D. PMID: 11535593.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansAnimalsCells
    52. Nuclear localization of EGF receptor and its potential new role as a transcription factor. Nat Cell Biol. 2001 Sep; 3(9):802-8. Lin SY, Makino K, Xia W, Matin A, Wen Y, Kwong KY, Bourguignon L, Hung MC. PMID: 11533659.
      View in: PubMed   Mentions: 406     Fields:    Translation:HumansAnimalsCells
    53. CD44-mediated oncogenic signaling and cytoskeleton activation during mammary tumor progression. J Mammary Gland Biol Neoplasia. 2001 Jul; 6(3):287-97. Bourguignon LY. PMID: 11547898.
      View in: PubMed   Mentions: 51     Fields:    Translation:HumansCells
    54. Forensic archaeology, forensic anthropology and human rights in Europe. Sci Justice. 2001 Jul-Sep; 41(3):173-8. Hunter JR, Brickley MB, Bourgeois J, Bouts W, Bourguignon L, Hubrecht F, De Winne J, Van Haaster H, Hakbijl T, De Jong H, Smits L, Van Wijngaarden LH, Luschen M. PMID: 11515163.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    55. A novel CD44 v3 isoform is involved in head and neck squamous cell carcinoma progression. Otolaryngol Head Neck Surg. 2001 Apr; 124(4):426-32. Franzmann EJ, Weed DT, Civantos FJ, Goodwin WJ, Bourguignon LY. PMID: 11283501.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansCells
    56. Expression of Sonic Hedgehog downstream genes is modified in rat embryos exposed in utero to a distal inhibitor of cholesterol biosynthesis. Dev Dyn. 2001 Feb; 220(2):99-111. Gofflot F, Gaoua W, Bourguignon L, Roux C, Picard JJ. PMID: 11169843.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansAnimals
    57. CD44 interaction with c-Src kinase promotes cortactin-mediated cytoskeleton function and hyaluronic acid-dependent ovarian tumor cell migration. J Biol Chem. 2001 Mar 09; 276(10):7327-36. Bourguignon LY, Zhu H, Shao L, Chen YW. PMID: 11084024.
      View in: PubMed   Mentions: 90     Fields:    Translation:HumansAnimalsCells
    58. Ankyrin-Tiam1 interaction promotes Rac1 signaling and metastatic breast tumor cell invasion and migration. J Cell Biol. 2000 Jul 10; 150(1):177-91. Bourguignon LY, Zhu H, Shao L, Chen YW. PMID: 10893266; PMCID: PMC2185563.
      View in: PubMed   Mentions: 40     Fields:    Translation:AnimalsCells
    59. Selective down-regulation of IP(3)receptor subtypes by caspases and calpain during TNF alpha -induced apoptosis of human T-lymphoma cells. Cell Calcium. 2000 Jun; 27(6):315-28. Diaz F, Bourguignon LY. PMID: 11013462.
      View in: PubMed   Mentions: 20     Fields:    Translation:HumansCells
    60. Interaction between CD44 and the repeat domain of ankyrin promotes hyaluronic acid-mediated ovarian tumor cell migration. J Cell Physiol. 2000 May; 183(2):182-95. Zhu D, Bourguignon LY. PMID: 10737894.
      View in: PubMed   Mentions: 22     Fields:    Translation:HumansCells
    61. CD44 interaction with tiam1 promotes Rac1 signaling and hyaluronic acid-mediated breast tumor cell migration. J Biol Chem. 2000 Jan 21; 275(3):1829-38. Bourguignon LY, Zhu H, Shao L, Chen YW. PMID: 10636882.
      View in: PubMed   Mentions: 87     Fields:    Translation:AnimalsCells
    62. A new CD44V3-containing isoform is involved in tumor cell growth and migration during human breast carcinoma progression. Front Biosci. 1999 Jan 01; 4:A1-8. Kalish ED, Iida N, Moffat FL, Bourguignon LY. PMID: 9872731.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCells
    63. Rho-kinase (ROK) promotes CD44v(3,8-10)-ankyrin interaction and tumor cell migration in metastatic breast cancer cells. Cell Motil Cytoskeleton. 1999; 43(4):269-87. Bourguignon LY, Zhu H, Shao L, Zhu D, Chen YW. PMID: 10423269.
      View in: PubMed   Mentions: 56     Fields:    Translation:HumansAnimalsCells
    64. CD44 isoform-cytoskeleton interaction in oncogenic signaling and tumor progression. Front Biosci. 1998 Jul 01; 3:d637-49. Bourguignon LY, Zhu D, Zhu H. PMID: 9634539.
      View in: PubMed   Mentions: 32     Fields:    Translation:HumansAnimalsCells
    65. CD44v(3,8-10) is involved in cytoskeleton-mediated tumor cell migration and matrix metalloproteinase (MMP-9) association in metastatic breast cancer cells. J Cell Physiol. 1998 Jul; 176(1):206-15. Bourguignon LY, Gunja-Smith Z, Iida N, Zhu HB, Young LJ, Muller WJ, Cardiff RD. PMID: 9618160.
      View in: PubMed   Mentions: 93     Fields:    Translation:AnimalsCells
    66. The ankyrin-binding domain of CD44s is involved in regulating hyaluronic acid-mediated functions and prostate tumor cell transformation. Cell Motil Cytoskeleton. 1998; 39(3):209-22. Zhu D, Bourguignon LY. PMID: 9519902.
      View in: PubMed   Mentions: 22     Fields:    Translation:HumansCells
    67. Co-expression of bcl-2 and CD44s in basal layers of human ocular surface epithelia. Adv Exp Med Biol. 1998; 438:527-31. Huang AJ, Li CH, Chen YW, Bourguignon LY. PMID: 9634932.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    68. Interaction between the adhesion receptor, CD44, and the oncogene product, p185HER2, promotes human ovarian tumor cell activation. J Biol Chem. 1997 Oct 31; 272(44):27913-8. Bourguignon LY, Zhu H, Chu A, Iida N, Zhang L, Hung MC. PMID: 9346940.
      View in: PubMed   Mentions: 71     Fields:    Translation:HumansCells
    69. Coexpression of CD44 variant (v10/ex14) and CD44S in human mammary epithelial cells promotes tumorigenesis. J Cell Physiol. 1997 May; 171(2):152-60. Iida N, Bourguignon LY. PMID: 9130462.
      View in: PubMed   Mentions: 23     Fields:    Translation:HumansAnimalsCells
    70. The cell adhesion molecule, GP116, is a new CD44 variant (ex14/v10) involved in hyaluronic acid binding and endothelial cell proliferation. J Biol Chem. 1996 Sep 27; 271(39):23853-64. Lokeshwar VB, Iida N, Bourguignon LY. PMID: 8798616.
      View in: PubMed   Mentions: 21     Fields:    Translation:HumansAnimalsCells
    71. Fatty acid unsaturation increases expression and capping of murine lymphocyte CD44 and CD45. Nutrition. 1996 Sep; 12(9):616-22. Peck MD, Li Z, Han T, Wang W, Jy W, Ahn YS, Ziboh VA, Chu AJ, Bourguignon LY. PMID: 8878171.
      View in: PubMed   Mentions: 2     Fields:    Translation:AnimalsCells
    72. Involvement of CD44 and the cytoskeletal linker protein ankyrin in human neutrophil bacterial phagocytosis. J Cell Physiol. 1996 Sep; 168(3):638-47. Moffat FL, Han T, Li ZM, Peck MD, Falk RE, Spalding PB, Jy W, Ahn YS, Chu AJ, Bourguignon LY. PMID: 8816918.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCells
    73. Association of murine splenocyte CD3 complex to the cytoskeleton: absence of modulation by exogenous fatty acids. Cell Biol Int. 1996 Aug; 20(8):531-7. Peck MD, Li Z, Jy W, Chu AJ, Bourguignon LY. PMID: 8938986.
      View in: PubMed   Mentions: 3     Fields:    Translation:AnimalsCells
    74. Ca2+ signaling in endothelial cells stimulated by bradykinin: Ca2+ measurement in the mitochondria and the cytosol by confocal microscopy. Cell Calcium. 1996 Jul; 20(1):53-61. Donnadieu E, Bourguignon LY. PMID: 8864571.
      View in: PubMed   Mentions: 5     Fields:    Translation:AnimalsCells
    75. Supplemental L-arginine HCl augments bacterial phagocytosis in human polymorphonuclear leukocytes. J Cell Physiol. 1996 Jul; 168(1):26-33. Moffat FL, Han T, Li ZM, Peck MD, Jy W, Ahn YS, Chu AJ, Bourguignon LY. PMID: 8647919.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCells
    76. Overexpression of CD44 in pl85(neu)-transfected NIH3T3 cells promotes an up-regulation of hyaluronic acid-mediated membrane-cytoskeleton interaction and cell adhesion. Oncogene. 1996 Jun 06; 12(11):2309-14. Zhu D, Bourguignon L. PMID: 8649770.
      View in: PubMed   Mentions: 3     Fields:    Translation:AnimalsCells
    77. Interaction of CD44 variant isoforms with hyaluronic acid and the cytoskeleton in human prostate cancer cells. J Cell Physiol. 1995 Sep; 164(3):605-12. Welsh CF, Zhu D, Bourguignon LY. PMID: 7544357.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCells
    78. Ryanodine receptor-ankyrin interaction regulates internal Ca2+ release in mouse T-lymphoma cells. J Biol Chem. 1995 Jul 28; 270(30):17917-22. Bourguignon LY, Chu A, Jin H, Brandt NR. PMID: 7629097.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansAnimalsCells
    79. Identification of the ankyrin-binding domain of the mouse T-lymphoma cell inositol 1,4,5-trisphosphate (IP3) receptor and its role in the regulation of IP3-mediated internal Ca2+ release. J Biol Chem. 1995 Mar 31; 270(13):7257-60. Bourguignon LY, Jin H. PMID: 7706265.
      View in: PubMed   Mentions: 23     Fields:    Translation:AnimalsCells
    80. New CD44 splice variants associated with human breast cancers. J Cell Physiol. 1995 Jan; 162(1):127-33. Iida N, Bourguignon LY. PMID: 7529235.
      View in: PubMed   Mentions: 40     Fields:    Translation:HumansCells
    81. Mapping the fodrin binding domain in CD45, a leukocyte membrane-associated tyrosine phosphatase. J Biol Chem. 1994 Nov 18; 269(46):28576-83. Iida N, Lokeshwar VB, Bourguignon LY. PMID: 7961804.
      View in: PubMed   Mentions: 9     Fields:    Translation:AnimalsCells
    82. Ankyrin-binding domain of CD44(GP85) is required for the expression of hyaluronic acid-mediated adhesion function. J Cell Biol. 1994 Aug; 126(4):1099-109. Lokeshwar VB, Fregien N, Bourguignon LY. PMID: 7519619; PMCID: PMC2120123.
      View in: PubMed   Mentions: 58     Fields:    Translation:HumansAnimalsCells
    83. A new splice variant of the inositol-1,4,5-triphosphate (IP3) receptor. Cell Signal. 1994 May; 6(4):449-55. Iida N, Bourguignon LY. PMID: 7946968.
      View in: PubMed   Mentions:    Fields:    Translation:AnimalsCells
    84. Identification of an IP3 receptor in endothelial cells. J Cell Physiol. 1994 Apr; 159(1):29-34. Bourguignon LY, Iida N, Sobrin L, Bourguignon GJ. PMID: 8138588.
      View in: PubMed   Mentions: 6     Fields:    Translation:AnimalsCells
    85. Hyaluronic acid-induced lymphocyte signal transduction and HA receptor (GP85/CD44)-cytoskeleton interaction. J Immunol. 1993 Dec 15; 151(12):6634-44. Bourguignon LY, Lokeshwar VB, Chen X, Kerrick WG. PMID: 7505012.
      View in: PubMed   Mentions: 25     Fields:    Translation:AnimalsCells
    86. The involvement of the cytoskeleton in regulating IP3 receptor-mediated internal Ca2+ release in human blood platelets. Cell Biol Int. 1993 Aug; 17(8):751-8. Bourguignon LY, Iida N, Jin H. PMID: 8220303.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCells
    87. The involvement of ankyrin in the regulation of inositol 1,4,5-trisphosphate receptor-mediated internal Ca2+ release from Ca2+ storage vesicles in mouse T-lymphoma cells. J Biol Chem. 1993 Apr 05; 268(10):7290-7. Bourguignon LY, Jin H, Iida N, Brandt NR, Zhang SH. PMID: 8385102.
      View in: PubMed   Mentions: 38     Fields:    Translation:HumansAnimalsCells
    88. The lymphoma transmembrane glycoprotein GP85 (CD44) is a novel guanine nucleotide-binding protein which regulates GP85 (CD44)-ankyrin interaction. J Biol Chem. 1992 Nov 05; 267(31):22073-8. Lokeshwar VB, Bourguignon LY. PMID: 1429559.
      View in: PubMed   Mentions: 16     Fields:    Translation:Cells
    89. Tyrosine phosphatase activity of lymphoma CD45 (GP180) is regulated by a direct interaction with the cytoskeleton. J Biol Chem. 1992 Oct 25; 267(30):21551-7. Lokeshwar VB, Bourguignon LY. PMID: 1400466.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansAnimalsCells
    90. A CD44-like endothelial cell transmembrane glycoprotein (GP116) interacts with extracellular matrix and ankyrin. Mol Cell Biol. 1992 Oct; 12(10):4464-71. Bourguignon LY, Lokeshwar VB, He J, Chen X, Bourguignon GJ. PMID: 1406635; PMCID: PMC360371.
      View in: PubMed   Mentions: 23     Fields:    Translation:AnimalsCells
    91. The involvement of Ca2+ and myosin light chain kinase in collagen-induced platelet activation. Cell Biol Int Rep. 1992 Sep; 16(9):883-97. Lokeshwar VB, Bourguignon LY. PMID: 1423657.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    92. Post-translational protein modification and expression of ankyrin-binding site(s) in GP85 (Pgp-1/CD44) and its biosynthetic precursors during T-lymphoma membrane biosynthesis. J Biol Chem. 1991 Sep 25; 266(27):17983-9. Lokeshwar VB, Bourguignon LY. PMID: 1833390.
      View in: PubMed   Mentions: 34     Fields:    Translation:AnimalsCells
    93. Acylation of the lymphoma transmembrane glycoprotein, GP85, may be required for GP85-ankyrin interaction. J Biol Chem. 1991 Jun 25; 266(18):11761-5. Bourguignon LY, Kalomiris EL, Lokeshwar VB. PMID: 1828806.
      View in: PubMed   Mentions: 21     Fields:    Translation:AnimalsCells
    94. Membrane-associated 41-kDa GTP-binding protein in collagen-induced platelet activation. FASEB J. 1990 Aug; 4(11):2925-33. Walker G, Bourguignon LY. PMID: 2116341.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    95. Interactions between a lymphoma membrane-associated guanosine 5'-triphosphate-binding protein and the cytoskeleton during receptor patching and capping. J Immunol. 1990 Mar 15; 144(6):2242-52. Bourguignon LY, Walker G, Huang HS. PMID: 1968926.
      View in: PubMed   Mentions: 7     Fields:    Translation:AnimalsCells
    96. Role of Ca2+ in the regulation of hormone receptor exposure during lymphocyte activation. Biochim Biophys Acta. 1989 Aug 07; 983(2):153-60. Jy W, Fregien N, Bourguignon GJ, Bourguignon LY. PMID: 2503037.
      View in: PubMed   Mentions: 2     Fields:    Translation:AnimalsCells
    97. Electric stimulation of human fibroblasts causes an increase in Ca2+ influx and the exposure of additional insulin receptors. J Cell Physiol. 1989 Aug; 140(2):379-85. Bourguignon GJ, Jy W, Bourguignon LY. PMID: 2663886.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCells
    98. Lymphoma protein kinase C is associated with the transmembrane glycoprotein, GP85, and may function in GP85-ankyrin binding. J Biol Chem. 1989 May 15; 264(14):8113-9. Kalomiris EL, Bourguignon LY. PMID: 2470741.
      View in: PubMed   Mentions: 20     Fields:    Translation:AnimalsCells
    99. The role of caldesmon in the regulation of receptor capping in mouse T-lymphoma cell. J Biol Chem. 1989 Jan 05; 264(1):496-500. Walker G, Kerrick WG, Bourguignon LY. PMID: 2909534.
      View in: PubMed   Mentions: 14     Fields:    Translation:AnimalsCells
    100. Nuclear disintegration of target cells by killer B lymphocytes from tumor-bearing mice. FASEB J. 1989 Jan; 3(1):37-43. Lopez DM, Blomberg BB, Padmanabhan RR, Bourguignon LY. PMID: 2783411.
      View in: PubMed   Mentions: 3     Fields:    Translation:AnimalsCells
    101. Insulin-induced myosin light-chain phosphorylation during receptor capping in IM-9 human B-lymphoblasts. Biochem J. 1988 Jun 15; 252(3):815-23. Majercik MH, Bourguignon LY. PMID: 3048249; PMCID: PMC1149220.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    102. Lymphocyte activation and capping of hormone receptors. J Cell Biochem. 1988 Jun; 37(2):131-50. Bourguignon LY, Jy W, Majercik MH, Bourguignon GJ. PMID: 3135294.
      View in: PubMed   Mentions: 1     Fields:    Translation:AnimalsCells
    103. Effect of cyclic AMP on human blood platelets: induction of pseudopod formation and protein phosphorylation. Cell Biol Int Rep. 1988 Apr; 12(4):271-88. Maurer DR, Majercik MH, Bourguignon LY. PMID: 2841028.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    104. Mouse T lymphoma cells contain a transmembrane glycoprotein (GP85) that binds ankyrin. J Cell Biol. 1988 Feb; 106(2):319-27. Kalomiris EL, Bourguignon LY. PMID: 2963010; PMCID: PMC2114978.
      View in: PubMed   Mentions: 47     Fields:    Translation:AnimalsCells
    105. Isolation of Thy-1 caps and analysis of their phospholipid composition in mouse T-lymphoma cells. J Cell Physiol. 1988 Jan; 134(1):67-77. Suchard SJ, Lo HK, Bourguignon LY. PMID: 2826503.
      View in: PubMed   Mentions:    Fields:    Translation:AnimalsCells
    106. Electric stimulation of protein and DNA synthesis in human fibroblasts. FASEB J. 1987 Nov; 1(5):398-402. Bourguignon GJ, Bourguignon LY. PMID: 3678699.
      View in: PubMed   Mentions: 35     Fields:    Translation:HumansCells
    107. Further characterization of a fodrin-containing transmembrane complex from mouse T-lymphoma cells. Biochim Biophys Acta. 1987 Jan 09; 896(1):35-46. Suchard SJ, Bourguignon LY. PMID: 3491628.
      View in: PubMed   Mentions: 1     Fields:    Translation:AnimalsCells
    108. Lymphoma Thy-1 glycoprotein is linked to the cytoskeleton via a 4.1-like protein. J Cell Biol. 1986 Dec; 103(6 Pt 1):2529-40. Bourguignon LY, Suchard SJ, Kalomiris EL. PMID: 2877998; PMCID: PMC2114603.
      View in: PubMed   Mentions: 8     Fields:    Translation:AnimalsCells
    109. A lymphoma plasma membrane-associated protein with ankyrin-like properties. J Cell Biol. 1986 Jun; 102(6):2115-24. Bourguignon LY, Walker G, Suchard SJ, Balazovich K. PMID: 2940251; PMCID: PMC2114262.
      View in: PubMed   Mentions: 14     Fields:    Translation:AnimalsCells
    110. Endocytosis of mannose-6-phosphate binding sites by mouse T-lymphoma cells. J Cell Physiol. 1986 Apr; 127(1):146-61. Bourguignon LY, Balazovich K, Suchard SJ, Hindsgaul O, Pierce M. PMID: 2870071.
      View in: PubMed   Mentions:    Fields:    Translation:AnimalsCells
    111. Phorbol ester-induced phosphorylation of a transmembrane glycoprotein (GP 180) in human blood platelets. J Biol Chem. 1985 Sep 25; 260(21):11775-80. Bourguignon LY, Walker G, Bourguignon GJ. PMID: 4044578.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    112. Insulin receptor capping and its correlation with calmodulin-dependent myosin light chain kinase. J Cell Physiol. 1985 Sep; 124(3):403-10. Majercik MH, Bourguignon LY. PMID: 2931441.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    113. A T-lymphoma transmembrane glycoprotein (gp180) is linked to the cytoskeletal protein, fodrin. J Cell Biol. 1985 Aug; 101(2):477-87. Bourguignon LY, Suchard SJ, Nagpal ML, Glenney JR. PMID: 3874872; PMCID: PMC2113658.
      View in: PubMed   Mentions: 39     Fields:    Translation:AnimalsCells
    114. Phosphorylation of a tropomyosin-like (30 KD) protein during platelet activation. J Cell Biochem. 1985; 29(1):19-30. Bourguignon LY, Field S, Bourguignon GJ. PMID: 4055920.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    115. The involvement of the cytoskeleton during antibody-dependent cellular cytotoxicity (ADCC). Cell Biol Int Rep. 1984 Nov; 8(11):923-38. Balazovich KJ, Lopez DM, Bourguignon LY. PMID: 6542457.
      View in: PubMed   Mentions:    Fields:    Translation:AnimalsCells
    116. Cell cycle related phenothiazine effects on adriamycin transport. Cell Biol Int Rep. 1984 Jun; 8(6):449-56. Krishan A, Bourguignon LY. PMID: 6744425.
      View in: PubMed   Mentions: 1     Fields:    Translation:Animals
    117. Regulation of receptor capping in mouse lymphoma T cells by Ca2+-activated myosin light chain kinase. Proc Natl Acad Sci U S A. 1984 Jan; 81(1):165-9. Kerrick WG, Bourguignon LY. PMID: 6582474; PMCID: PMC344631.
      View in: PubMed   Mentions: 15     Fields:    Translation:AnimalsCells
    118. Receptor capping in platelet membranes. Cell Biol Int Rep. 1984 Jan; 8(1):19-26. Bourguignon LY. PMID: 6705052.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    119. Capping and the cytoskeleton. Int Rev Cytol. 1984; 87:195-224. Bourguignon LY, Bourguignon GJ. PMID: 6325363.
      View in: PubMed   Mentions: 39     Fields:    Translation:HumansAnimalsCells
    120. Comparison of cytoskeletal organization in canine distemper virus-infected and uninfected cells. J Gen Virol. 1983 Nov; 64 (Pt 11):2379-85. Howard JM, Eckert BS, Bourguignon LY. PMID: 6358405.
      View in: PubMed   Mentions: 5     Fields:    Translation:AnimalsCells
    121. The participation of adenylate cyclase in lymphocyte capping. Biochim Biophys Acta. 1983 Feb; 728(2):186-90. Bourguignon LY, Hsing YC. PMID: 6131691.
      View in: PubMed   Mentions: 1     Fields:    Translation:AnimalsCells
    122. Cell cycle dependent receptor capping in mouse leukemic cells. Cell Biol Int Rep. 1983 Feb; 7(2):109-19. Bourguignon LY, Rubin RW, Krishan A. PMID: 6340839.
      View in: PubMed   Mentions: 1     Fields:    Translation:AnimalsCells
    123. Receptor capping in mouse T-lymphoma cells: a Ca2+ and calmodulin-stimulated ATP-dependent process. J Membr Biol. 1983; 75(1):65-72. Bourguignon LY, Kerrick WG. PMID: 6604166.
      View in: PubMed   Mentions: 5     Fields:    Translation:AnimalsCells
    124. Stimulation of lymphocyte receptor capping by the ionophore monensin. J Membr Biol. 1983; 73(1):91-3. Bourguignon LY, Pressman BC. PMID: 6134837.
      View in: PubMed   Mentions: 3     Fields:    Translation:AnimalsCells
    125. Association of myosin light chain kinase with lymphocyte membrane-cytoskeleton complex. J Cell Biol. 1982 Dec; 95(3):793-7. Bourguignon LY, Nagpal ML, Balazovich K, Guerriero V, Means AR. PMID: 6984047; PMCID: PMC2112919.
      View in: PubMed   Mentions: 10     Fields:    Translation:AnimalsCells
    126. Immunoelectron microscopic localization of Thy-1 glycoprotein in wild type and Thy-1-negative lymphoma cells. Cell Biol Int Rep. 1982 Aug; 6(8):745-55. Bourguignon LY, Balazovich K, Trowbridge IS, Hyman R. PMID: 6127167.
      View in: PubMed   Mentions: 3     Fields:    Translation:AnimalsCells
    127. Morphological analysis of surface immunoglobulin biosynthesis in mouse B lymphoid cells using immunoelectron microscopy. Cell Immunol. 1982 Jul 15; 71(1):27-43. Bourguignon LY, Butman BT. PMID: 6183010.
      View in: PubMed   Mentions: 1     Fields:    Translation:AnimalsCells
    128. Intracellular localization of certain membrane glycoproteins in mouse T-lymphoma cells using immunoferritin staining of ultrathin frozen sections. J Cell Physiol. 1982 Feb; 110(2):203-12. Bourguignon LY, Butman BT. PMID: 6121821.
      View in: PubMed   Mentions: 2     Fields:    Translation:AnimalsCells
    129. Phosphorylation of myosin light chain during capping of mouse T-lymphoma cells. J Cell Biol. 1981 Dec; 91(3 Pt 1):889-94. Bourguignon LY, Nagpal ML, Hsing YC. PMID: 6976966; PMCID: PMC2112802.
      View in: PubMed   Mentions: 11     Fields:    Translation:AnimalsCells
    130. Isolation and initial characterization of a lymphocyte cap structure. Biochim Biophys Acta. 1981 Aug 06; 646(1):109-18. Bourguignon GJ, Bourguignon LY. PMID: 6268160.
      View in: PubMed   Mentions: 1     Fields:    Translation:AnimalsCells
    131. Immunocytochemical localization of intermediate filament proteins during lymphocyte capping. Cell Biol Int Rep. 1981 Aug; 5(8):783-9. Bourguignon LY, Bourguignon GJ. PMID: 7026056.
      View in: PubMed   Mentions: 1     Fields:    Translation:AnimalsCells
    132. The involvement of cAMP in lymphocyte capping. Cell Immunol. 1981 Jul 01; 61(2):397-403. Butman BT, Jacobsen T, Cabatu OG, Bourguignon LY. PMID: 6265104.
      View in: PubMed   Mentions: 5     Fields:    Translation:Animals
    133. The capping of liposomes on the surface of murine lymphoid and leukemic cells. Cell Mol Biol Incl Cyto Enzymol. 1981; 27(2-3):215-21. Rader RL, Bourguignon LY. PMID: 7197586.
      View in: PubMed   Mentions: Translation:AnimalsCells
    134. Lymphocyte capping induced by polycationized ferritin. J Cell Physiol. 1980 Oct; 105(1):7-15. Butman BT, Bourguignon GJ, Bourguignon LY. PMID: 6253511.
      View in: PubMed   Mentions: 7     Fields:    Translation:AnimalsCells
    135. Effect of the antidepressant drug-Stelazine on lymphocyte capping. Cell Biol Int Rep. 1980 Oct; 4(10):947-52. Bourguignon LY, Balazovich K. PMID: 6968248.
      View in: PubMed   Mentions: 7     Fields:    Translation:AnimalsCells
    136. Simultaneous localization of intracellular myosin and surface concanavalin A receptor clusters using immuno-electron microscopy. Cell Biol Int Rep. 1980 Jun; 4(6):541-7. Bourguignon LY. PMID: 6994897.
      View in: PubMed   Mentions: 7     Fields:    Translation:AnimalsCells
    137. Capping of concanavalin A receptors and their association with microfilaments in monolayer grown human fibroblastoid cells. Cell Tissue Res. 1980; 205(1):77-84. Bourguignon LY, Rozek RJ. PMID: 7189138.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    138. Biochemical analysis of ligand-induced receptor patching and capping using a novel immunolactoperoxidase iodination technique. J Cell Biol. 1979 Dec; 83(3):649-56. Bourguignon LY. PMID: 391811; PMCID: PMC2110510.
      View in: PubMed   Mentions: 2     Fields:    Translation:AnimalsCells
    139. Rapid separation of mouse T and B lymphocytes using wheat germ agglutinin. J Cell Physiol. 1979 Apr; 99(1):95-9. Bourguignon LY, Rader RL, McMahon JT. PMID: 313400.
      View in: PubMed   Mentions: 2     Fields:    Translation:AnimalsCells
    140. The capping of lymphocytes and other cells, studied by an improved method for immunofluorescence staining of frozen sections. J Cell Physiol. 1978 Jun; 95(3):239-57. Bourguignon LY, Tokuyasu KT, Singer SJ. PMID: 77276.
      View in: PubMed   Mentions: 18     Fields:    Translation:Cells
    141. Localization of T25 glycoprotein in wild-type and Thy 1- mutant cells by immunofluorescence and immunoelectron microscopy. J Exp Med. 1978 May 01; 147(5):1348-54. Bourguignon LY, Hyman R, Trowbridge I, Singer SJ. PMID: 77306; PMCID: PMC2184277.
      View in: PubMed   Mentions: 2     Fields:    Translation:AnimalsCells
    142. Participation of histocompatibility antigens in capping of molecularly independent cell surface components by their specific antibodies. Proc Natl Acad Sci U S A. 1978 May; 75(5):2406-10. Bourguignon LY, Hyman R, Trowbridge I, Singer SJ. PMID: 307764; PMCID: PMC392562.
      View in: PubMed   Mentions: 27     Fields:    Translation:Cells
    143. Isolation and characterization of the RNA of membrane-bound ribosomes in Dictyostelium discoideum. J Gen Microbiol. 1978 May; 106(1):93-101. Bourguignon LY, Katz ER. PMID: 565802.
      View in: PubMed   Mentions:    Fields:    Translation:AnimalsCells
    144. Transmembrane interactions and the mechanisms of transport of proteins across membranes. J Supramol Struct. 1978; 9(3):373-89. Singer SJ, Ash JF, Bourguignon LY, Heggeness MH, Louvard D. PMID: 748682.
      View in: PubMed   Mentions: 19     Fields:    Translation:Cells
    145. Transmembrane interactions and the mechanism of capping of surface receptors by their specific ligands. Proc Natl Acad Sci U S A. 1977 Nov; 74(11):5031-5. Bourguignon LY, Singer SJ. PMID: 337308; PMCID: PMC432092.
      View in: PubMed   Mentions: 97     Fields:    Translation:AnimalsCells
    146. Incorporation of polypeptides into thylakoid membranes of Chlamydomonas reinhardtii. Cyclic variations. J Cell Biol. 1976 May; 69(2):327-44. Bourguignon LY, Palade GE. PMID: 1262393; PMCID: PMC2109681.
      View in: PubMed   Mentions: 6     Fields:    Translation:AnimalsCells
    147. The cell cycle and its relationship to aggregation in the cellular slime mold, Dictyostelium discoideum. Dev Biol. 1974 Jan; 36(1):82-7. Katz ER, Bourguignon LY. PMID: 4856682.
      View in: PubMed   Mentions: 6     Fields:    Translation:Animals
    Lilly's Networks
    Concepts (626)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (14)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UCSF Profiles is managed by the UCSF Clinical and Translational Science Institute (CTSI), part of the Clinical and Translational Science Award program funded by the National Center for Advancing Translational Sciences (Grant Number UL1 TR000004) at the National Institutes of Health (NIH).
    This site is running Profiles RNS version v3.1.0-871-g21b54b14 on PROFILES-PWEB02.

    Copyright © The Regents of the University of California